The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot
Moderna(US:MRNA) WSJ·2026-02-18 14:12Group 1 - The company's mRNA flu shot, if approved, could be available for the 2026-27 flu season [1]
Moderna(US:MRNA) WSJ·2026-02-18 14:12